University of Miami

Overview of the Arctic Sea State and Boundary Layer Physics Program (2018) Thomson J, Ackley S, Girard-Ardhuin F, Ardhuin F, Babanin A, Boutin G, Brozena J, et al. Journal article International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management (2018) Dent E, Morley JE, Cruz-Jentoft AJ, Arai H, Kritchevsky SB, Guralnik J, Bauer JM, et al. Journal article Treatment efficacyand safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis patients: 12-and 26-week analysis from an ongoing international, randomized, dose raging phase 2 study (2018) Hirschfield G, Boudes P, Bowlus C, Gitlin N, Michael G, Harrison S, Gordon SC, et al. Conference contribution International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease (2018) Williamson K, Lytvyak E, Kremer A, De Krijger M, Trivedi P, Estes D, Yu L, et al. Conference contribution Analyzing relative blood flow speeds in choroidal neovascularization using variable interscan time analysis OCT angiography (2018) Rebhun CB, Moult EM, Ploner S, Moreira-Neto C, Alibhai AY, Schottenhamml J, Lee B, et al. Journal article, Medical case study OCT-OCTA Segmentation (2018) Schottenhamml J, Moult EM, Novais EA, Kraus M, Lee B, Choi W, Ploner S, et al. Conference contribution, Abstract of a poster Efficacy and Safety of Seladelpar, a Selective Peroxisome Proliferator-Activated Receptor Delta Agonist, in Primary Biliary Cholangitis: 52-Week Analysis of an Ongoing International, Randomized, Dose Ranging Phase 2 Study (2018) Bowlus CL, Neff GW, Aspinall R, Galambos MR, Goel A, Hirschfield G, Kremer A, et al. Conference contribution Consensus recommendations for trabecular meshwork cell isolation, characterization and culture (2018) Keller KE, Bhattacharya SK, Borras T, Brunner TM, Chansangpetch S, Clark AF, Dismuke WM, et al. Journal article A conserved Eph family receptor-binding motif on the gH/gL complex of Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus (2018) Grosskopf AK, Enßer A, Neipel F, Jungnickl D, Schlagowski S, Desrosiers RC, Hahn AS Journal article Upadacitinib improves steroid-free clinical and endoscopic endpoints in patients with Crohn's disease: Data from the CELEST study (2018) Panaccione R, Atreya R, Ferrante M, Dubinsky MC, Sands BE, Abreu MT, Cataldi F, et al. Conference contribution